MULTIPLEXED IMMUNOBEAD-BASED PROFILING OF CYTOKINE MARKERS FOR DETECTION OF NASOPHARYNGEAL CARCINOMA AND PROGNOSIS OF PATIENT SURVIVAL

被引:55
作者
Chang, Kai-Ping [2 ]
Chang, Ya-Ting [5 ]
Wu, Chih-Ching [1 ]
Liu, Yu-Ling [1 ]
Chen, Min-Chi [6 ]
Tsang, Ngan-Ming [3 ]
Hsu, Cheng-Lung [4 ]
Chang, Yu-Sun [1 ,5 ]
Yu, Jau-Song [1 ,7 ]
机构
[1] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan, Taiwan
[2] Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Linkou, Taiwan
[3] Chang Gung Mem Hosp, Dept Radiat Oncol, Linkou, Taiwan
[4] Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Linkou, Taiwan
[5] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan
[6] Chang Gung Univ, Publ Hlth & Biostat Consulting Ctr, Tao Yuan, Taiwan
[7] Chang Gung Univ, Dept Cell & Mol Biol, Tao Yuan, Taiwan
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2011年 / 33卷 / 06期
关键词
nasopharyngeal carcinoma; immunobead; tumor marker; Epstein-Barr virus; cytokine; EPSTEIN-BARR-VIRUS; LATENT MEMBRANE PROTEIN-1; ENDOTHELIAL GROWTH-FACTOR; SERUM ANTIBODIES; CHEMOKINE IP-10; T-LYMPHOCYTES; UP-REGULATION; EXPRESSION; CELLS; TUMOR;
D O I
10.1002/hed.21557
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. The purpose of this study was to examine cytokine profiles of peripheral blood for nasopharyngeal carcinoma (NPC). Methods. A total of 132 patients with untreated NPC, 169 healthy individuals, and 32 patients with chronic rhinosinusitis (CRS) were enrolled in this study. The plasma levels of 13 cytokines were measured by the multiplexed immunobead-based method. Results. The levels of interleukin (IL)-6, IL-8, interferon-inducible protein 10 (IP-10), tumor necrosis factor (TNF)-alpha, vascular endothelial growth factor (VEGF), and macrophage inflammatory protein (MIP)-3 alpha were significantly elevated in patients with NPC; but the stem cell factor (SCF) levels were significantly lower. The levels of IL-6, IL-8, IP-10, and MIP-3 alpha were significantly elevated in patients with advanced stages disease and correlated with Epstein-Barr virus (EBV) DNA. A 2-marker panel consisting of MIP-3 alpha and SCF increased the screening efficacy of EBV-specific viral capsid antigen (VCA) IgA or EBV DNA, although the addition of MIP-3 alpha and SCF to the combined set of currently available markers (EBV VCA IgA and EBV DNA) did not improve the accuracy of the diagnostic panel. The patients with NPC with higher levels of IL-8, VEGF, MIP-3 alpha, and EBV DNA had worse prognoses for overall survival (p = .008, .035, .005, and .007, respectively). Conclusion. Simultaneous, large-scale measurement of multiple cytokines may improve NPC detection and prognostic prediction. (C) 2010 Wiley Periodicals, Inc. Head Neck 33: 886-897, 2011
引用
收藏
页码:886 / 897
页数:12
相关论文
共 59 条
[31]   Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma [J].
Lin, JC ;
Wang, WY ;
Chen, KY ;
Wei, YH ;
Liang, WM ;
Jan, JS ;
Jiang, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (24) :2461-2470
[32]   Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival [J].
Lin, JC ;
Jan, JS ;
Hsu, CY ;
Liang, WM ;
Jiang, RS ;
Wang, WY .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (04) :631-637
[33]   Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells [J].
Lo, Angela Kwok Fung ;
Lo, Kwok Wai ;
Tsao, Sai Wah ;
Wong, Hing Lok ;
Hui, Jan Wai Ying ;
To, Ka Fai ;
Hayward, S. Diane ;
Chui, Yiu Loon ;
Lau, Yu Lung ;
Takada, Kenzo ;
Huang, Dolly P. .
NEOPLASIA, 2006, 8 (03) :173-180
[34]  
Lo YMD, 1999, CANCER RES, V59, P1188
[35]   Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma [J].
Ma, Brigette B. Y. ;
King, Ann ;
Lo, Y. M. Dennis ;
Yau, Y. Y. ;
Zee, Benny ;
Hui, Edwin P. ;
Leung, Sing F. ;
Mo, Frankie ;
Kam, Michael K. ;
Ahuja, Anil ;
Kwan, Wing H. ;
Chan, Anthony T. C. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03) :714-720
[36]   Serum protein markers for early detection of ovarian cancer [J].
Mor, G ;
Visintin, I ;
Lai, Y ;
Zhao, H ;
Schwartz, P ;
Rutherford, T ;
Yue, L ;
Bray-Ward, P ;
Ward, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (21) :7677-7682
[37]   Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells [J].
Murono, S ;
Inoue, H ;
Tanabe, T ;
Joab, I ;
Yoshizaki, T ;
Furukawa, M ;
Pagano, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (12) :6905-6910
[38]   Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro [J].
O'Neil, John D. ;
Owen, Thomas J. ;
Wood, Victoria H. J. ;
Date, Kathryn L. ;
Valentine, Robert ;
Chukwuma, Marilyn B. ;
Arrand, John R. ;
Dawson, Christopher W. ;
Young, Lawrence S. .
JOURNAL OF GENERAL VIROLOGY, 2008, 89 :2833-2842
[39]  
O'Sullivan Brian, 2003, Semin Surg Oncol, V21, P30, DOI 10.1002/ssu.10019
[40]   RETRACTED: Transactivation of CCL20 gene by Epstein-Barr virus latent membrane protein 1 (Retracted article. See vol. 152, pg. 787, 2011) [J].
Okudaira, T ;
Yamamoto, K ;
Kawakami, H ;
Uchihara, JN ;
Tomita, M ;
Masuda, M ;
Matsuda, T ;
Sairenji, T ;
Iha, H ;
Jeang, KT ;
Matsuyama, T ;
Takasu, N ;
Mori, N .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (03) :293-302